As medical facilities become more equipped to handle different telemedicine platforms and procedures, more clinical trials are back up and running. This also means more electronic data is being generated than ever. This Ebook will explain how to reach patients and facilities, especially in this decentralized clinical trial format.
Related Posts
FDA Clears Alphamab’s Anti-HER2 Biparatopic Antibody-Drug Conjugate for Phase II Ovarian Cancer Trial
Image Credit: Adobe Stock Images/Pete Key Takeaways FDA Approval for JSKN003 Trial: Alphamab Oncology received FDA approval to start a…
Cardiff Reports 49% Response Rate With Onvansertib in RAS-Mutated Colorectal Cancer
Image Credit: © Sebastian Kaulitzki – stock.adobe.com Key takeaways The 30 mg onvansertib arm demonstrated a 49% confirmed ORR versus…
How Regulators are Viewing the Current Landscape of Clinical Technology
ACT: How are the regulators viewing this current “boom” in clinical technology? How has their stance on it changed over…